driven by
our mission

Since our beginning in 2014, Freenome has had a clear vision—to build a multi-disciplinary team with expertise in computational biology and machine learning techniques to detect cancer in its earliest, most treatable stages.

We are Freenomers

Freenomers are technical and creative, visionary and grounded, empathetic and passionate. We are building teams around divergent expertise, which allows us to solve problems and discover opportunities in unique ways.

We are technologists

We are programmers, machine learning experts, and computational biologists developing early cancer detection blood tests powered by our multiomics platform.

We are scientists

We are molecular biologists, clinicians, and sequencing experts working together to ensure the highest quality of scientific research and to develop the infrastructure necessary for next-generation early cancer detection and precision treatments.

We are people

All of us have been touched by cancer. Our experiences as patients and people lend urgency and meaning to the work we do every day, motivating us to equip all individuals and families with the tools they need to detect and treat cancer at its earliest and most manageable stages.

We are values-led

At Freenome, culture is front and center of everything we do—built on values that guide our decisions and actions, and are owned by every member of the team.



We seek to understand before being understood and build products that equitably serve diverse communities



We courageously do what is right, are fact-based, data-driven, and accountable for results



We recognize trust is built over time and value long-term relationships, not short-term transactions



We choose to take on cancer not because it’s easy, but because it’s hard



We lead by example and help others grow to their full potential

We are committed to quality

At Freenome, our mission is to empower everyone to prevent, detect, and treat disease by developing high-quality diagnostic tests.

We accomplish our quality objectives by maintaining an effective quality management system that is patient and customer—focused.

We are dedicated to continuous innovation and improvement in all aspects of our business.

Quality is the responsibility of every Freenome employee. Our executive management is actively involved in establishing, maintaining, and monitoring our quality system, and ensures adequate focus and resourcing.

We prioritize privacy

The security of the data that Freenome keeps on behalf of patients and partners is critically important and one of our most important responsibilities.

We have implemented state-of-the-art physical, administrative, and technical safeguards to protect the integrity and availability of data.

We are funded by leading investors

Since we were founded in 2014, the promise of our multiomics platform for early cancer detection through a blood draw has attracted over $1.1 billion in total financing from leading healthcare and technology investors.